Literature DB >> 31006081

Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1.

Grazia Maria Virzì1,2, Andrea Breglia3,4, Chiara Castellani5, Ghada Ankawi3,6, Chiara Bolin7, Massimo de Cal8,3, Vito Cianci4, Annalisa Angelini5, Giorgio Vescovo7,9, Claudio Ronco8,3,10.   

Abstract

BACKGROUND: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury. In this study, we evaluate the role of lipopolysaccharide (LPS) and various inflammatory markers in the developing acute kidney injury (AKI) in acute heart failure (AHF) patients.
METHODS: We enrolled 31 AHF patients and 20 CRS type 1 (the cause of AKI was presumed to be related to cardiac dysfunction) and 17 healthy volunteers without AHF, AKI or CKD, as control group (CTR). We assessed levels of LPS, proinflammatory cytokines (TNF-α, IL-6, IL-18), and oxidative stress marker (myeloperoxidase, MPO).
RESULTS: We observed a significant increase in LPS, TNF-α, IL-6, IL-18 and MPO levels in CRS type 1 and AHF group compared to CTR. LPS levels resulted significantly higher in CRS type 1 patients compared with AHF (118.2 pg/mL, IQR 77.8-217.6 versus 13.5 pg/mL, IQR 12.0-17.0, p = 0.008). We found a cytokines and oxidative stress dysregulation in CRS type 1 patients compared with AHF. Furthermore, we observed a strong positive significant correlation between LPS levels and IL-6 (Spearman's rho = 0.79, p < 0.001), and IL-18 (Spearman's rho = 0.77, p < 0.001) and MPO (Spearman's rho = 0.80, p < 0.001), all confirm by simple linear regression analysis.
CONCLUSION: CRS type 1 patients presented an increased level of LPS, pro-inflammatory cytokines, and MPO. Furthermore, there is a direct correlation between LPS and pro-inflammatory cytokines and stress oxidative marker. LPS may play a role in the pathophysiology of CRS type 1 inducing inflammation, oxidative stress and finally kidney damage.

Entities:  

Keywords:  Cardiorenal syndrome; Cytokines; Heart failure; Inflammation; Lipopolysaccharide; Oxidative stress

Year:  2019        PMID: 31006081     DOI: 10.1007/s40620-019-00613-2

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  34 in total

Review 1.  Direct effects of endotoxin on the endothelium: barrier function and injury.

Authors:  D D Bannerman; S E Goldblum
Journal:  Lab Invest       Date:  1999-10       Impact factor: 5.662

Review 2.  Post-injury multiple organ failure: the role of the gut.

Authors:  H T Hassoun; B C Kone; D W Mercer; F G Moody; N W Weisbrodt; F A Moore
Journal:  Shock       Date:  2001-01       Impact factor: 3.454

3.  Levosimendan protects against experimental endotoxemic acute renal failure.

Authors:  Richard A Zager; Ali C Johnson; Steve Lund; Sherry Y Hanson; Christine K Abrass
Journal:  Am J Physiol Renal Physiol       Date:  2006-01-17

Review 4.  Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy?

Authors:  René Celis; Guillermo Torre-Martinez; Guillermo Torre-Amione
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

5.  Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

Authors:  J Niebauer; H D Volk; M Kemp; M Dominguez; R R Schumann; M Rauchhaus; P A Poole-Wilson; A J Coats; S D Anker
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

Review 6.  LPS induction of gene expression in human monocytes.

Authors:  M Guha; N Mackman
Journal:  Cell Signal       Date:  2001-02       Impact factor: 4.315

7.  Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients.

Authors:  Simone Gonçalves; Roberto Pecoits-Filho; Sônia Perreto; Silvio H Barberato; Andréa E M Stinghen; Emmanuel G A Lima; Roseana Fuerbringer; Sirlene M Sauthier; Miguel C Riella
Journal:  Nephrol Dial Transplant       Date:  2006-07-21       Impact factor: 5.992

8.  Selective intestinal decontamination in advanced chronic heart failure: a pilot trial.

Authors:  Viviane M Conraads; Philippe G Jorens; Luc S De Clerck; Hendrik K Van Saene; Margaretha M Ieven; Johan M Bosmans; Annemie Schuerwegh; Chris H Bridts; Floris Wuyts; Wim J Stevens; Stefan D Anker; Mathias Rauchhaus; Christiaan J Vrints
Journal:  Eur J Heart Fail       Date:  2004-06       Impact factor: 15.534

Review 9.  Role of bacterial endotoxin in chronic heart failure: the gut of the matter.

Authors:  Bambos M Charalambous; Robert C M Stephens; Ian M Feavers; H E Montgomery
Journal:  Shock       Date:  2007-07       Impact factor: 3.454

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  2 in total

1.  Grb2 Induces Cardiorenal Syndrome Type 3: Roles of IL-6, Cardiomyocyte Bioenergetics, and Akt/mTOR Pathway.

Authors:  Jin Wang; Xuefeng Sun; Xu Wang; Shaoyuan Cui; Ran Liu; Jiaona Liu; Bo Fu; Ming Gong; Conghui Wang; Yushen Shi; Qianqian Chen; Guangyan Cai; Xiangmei Chen
Journal:  Front Cell Dev Biol       Date:  2021-03-22

Review 2.  Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment.

Authors:  Kang Fu; Yue Hu; Hui Zhang; Chen Wang; Zongwei Lin; Huixia Lu; Xiaoping Ji
Journal:  Front Cardiovasc Med       Date:  2021-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.